Company / Cash per Share
Amylyx Pharmaceuticals, Inc. Cash per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.06
FY2025
5-year range
$1.13 / $8.91
FY2021-FY2025
Trend
+82.9%
vs FY2024
Sector context
#102 of 205
Health Care
What the data says
At $2.06, Amylyx Pharmaceuticals, Inc.'s cash per share ranks #102 of 205 in the Health Care sector. Cash per Share returned to growth in FY2025 after 2 years of decline, reaching $2.06.
Based on SEC 10-K filings.
2.06 in FY2025 with a 3-year CAGR of -38.6%.
Declined from $2.51 to $2.06 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -38.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#102 of 205 in Health CareTop 50% of 205This company $2.06 Sector average $72.93
▼
-97.2% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 82.9% year-over-year.
- Ranks #102 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2022.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.06 | +82.9% |
| FY2024 | $1.13 | -55.1% |
| FY2023 | $2.51 | -71.8% |
| FY2022 | $8.91 | +16.9% |
| FY2021 | $7.62 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026